Literature DB >> 23765256

The role of food for the formation and prevention of gastrointestinal lesions induced by aspirin in cats.

Hiroshi Satoh1, Kikuko Amagase, Koji Takeuchi.   

Abstract

BACKGROUND/AIMS: The effects of feeding conditions (fasted or fed) and dietary fiber (DF) in the diet on gastrointestinal (GI) damage induced by aspirin (ASA) were examined in cats.
METHODS: Plain ASA (P-ASA, 20 mg/kg) or one enteric-coated ASA tablet (EC-ASA, containing 100 mg ASA) was administered p.o. once daily for 3 or 7 days just after morning meal, 3 h after the evening meal, or in the morning without a morning meal (fasted). Several types of diet, dry food (DRY, DF: 2.8 %), canned food (CAN, DF: 0.4 %), and diets with added cellulose or pectin were provided twice daily.
RESULTS: P-ASA or EC-ASA administered just after feeding of DRY caused marked lesions in the GI tract, although EC-ASA did not produce any lesions in the stomach. GI damage was markedly decreased when ASA was administered 3 h after the evening meal. The induction of lesions by EC-ASA was markedly decreased in cats that ate CAN, but lesions were induced in cats fed CAN with added cellulose (6 %). The addition of pectin (6 %) to the DRY markedly decreased the induction of lesions by EC-ASA.
CONCLUSIONS: The results indicate that the induction of GI lesions by ASA was highly dependent on the feeding conditions and DF. To minimize the induction of GI damage, it would be better to take ASA 3 h after the evening meal, or after consuming diets that contain low amounts of insoluble DF and high amounts of soluble DF.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23765256     DOI: 10.1007/s10620-013-2725-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

Review 1.  Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.

Authors:  Angel Lanas; James Scheiman
Journal:  Curr Med Res Opin       Date:  2007-01       Impact factor: 2.580

2.  Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.

Authors:  S Somasundaram; S Rafi; J Hayllar; G Sigthorsson; M Jacob; A B Price; A Macpherson; T Mahmod; D Scott; J M Wrigglesworth; I Bjarnason
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

3.  New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin.

Authors:  Kenichi Nonoyama; Kanako Nakagawa; Kikuko Amagase; Koji Takeuchi; Masahiko Nakamura; Susumu Okabe
Journal:  J Gastroenterol Hepatol       Date:  2010-05       Impact factor: 4.029

4.  Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.

Authors:  Hiroki Endo; Takuma Higurashi; Kunihiro Hosono; Eiji Sakai; Yusuke Sekino; Hiroshi Iida; Yasunari Sakamoto; Tomoko Koide; Hirokazu Takahashi; Masato Yoneda; Chikako Tokoro; Masahiko Inamori; Yasunobu Abe; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2011-05-10       Impact factor: 7.527

5.  Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin.

Authors:  N D Yeomans; A I Lanas; N J Talley; A B R Thomson; R Daneshjoo; B Eriksson; S Appelman-Eszczuk; G Långström; J Naesdal; P Serrano; M Singh; M M Skelly; C J Hawkey
Journal:  Aliment Pharmacol Ther       Date:  2005-11-01       Impact factor: 8.171

6.  Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage.

Authors:  Akiko Shiotani; Ken Haruma; Ryuji Nishi; Minoru Fujita; Tomoari Kamada; Keisuke Honda; Hiroaki Kusunoki; Jiro Hata; David Y Graham
Journal:  Scand J Gastroenterol       Date:  2010-03       Impact factor: 2.423

7.  Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin.

Authors:  Tilo Grosser; Susanne Fries; John A Lawson; Shiv C Kapoor; Gregory R Grant; Garret A FitzGerald
Journal:  Circulation       Date:  2012-12-04       Impact factor: 29.690

8.  Peripheral venous plasma aspirin concentrations and platelet aggregation inhibition produced by enteric-coated aspirin formulations.

Authors:  R A Brandon; J A Emmett; M J Eadie; A C Curran; I H Bunce
Journal:  Thromb Haemost       Date:  1986-04-30       Impact factor: 5.249

9.  Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers.

Authors:  Hiroki Endo; Kunihiro Hosono; Masahiko Inamori; Shingo Kato; Yuichi Nozaki; Kyoko Yoneda; Tomoyuki Akiyama; Koji Fujita; Hirokazu Takahashi; Masato Yoneda; Yasunobu Abe; Hiroyuki Kirikoshi; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Nobuyuki Matsuhashi; Atsushi Nakajima
Journal:  Digestion       Date:  2009-02-26       Impact factor: 3.216

10.  Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

Authors:  Kentaro Sugano; Yasushi Matsumoto; Tsukasa Itabashi; Sumihisa Abe; Nobuhiro Sakaki; Kiyoshi Ashida; Yuji Mizokami; Tsutomu Chiba; Shigeyuki Matsui; Tatsuya Kanto; Kazuyuki Shimada; Shinichiro Uchiyama; Naomi Uemura; Naoki Hiramatsu
Journal:  J Gastroenterol       Date:  2011-04-16       Impact factor: 7.527

View more
  3 in total

1.  Soluble Dietary Fiber Can Protect the Gastrointestinal Mucosa Against Nonsteroidal Anti-Inflammatory Drugs in Mice.

Authors:  Hiroshi Satoh; Tetsuro Urushidani
Journal:  Dig Dis Sci       Date:  2016-02-26       Impact factor: 3.199

2.  Soluble Dietary Fibers Can Protect the Small Intestinal Mucosa Without Affecting the Anti-inflammatory Effect of Indomethacin in Adjuvant-Induced Arthritis Rats.

Authors:  Hiroshi Satoh; Hiroki Matsumoto; Tomoe Hirakawa; Naoki Wada
Journal:  Dig Dis Sci       Date:  2015-09-30       Impact factor: 3.199

3.  ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Authors:  Stanley L Marks; Peter H Kook; Mark G Papich; M K Tolbert; Michael D Willard
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.